China Development Stock Report for the Third Quarter of 2024

SZSIOct 29, 2024 12:00 ET · Announcements

Beihai Gofar Chuanshan Biological (600538.SH) announced the performance for the first three quarters, with a net loss of 20.88 million yuan.

Beihai Gofar Chuanshan Biological (600538.SH) disclosed the third quarter report for 2024, and the company achieved operating income in the first three quarters...

Zhitong FinanceOct 29, 2024 11:29 ET

Beihai Gofar Chuanshan Biological (600538.SH): The net loss in the first three quarters was 20.8826 million yuan.

On October 29, beihai gofar chuanshan biological (600538.SH) announced that in the first three quarters of 2024, revenue reached 0.263 billion yuan, a decrease of 6.99% year-on-year; the net income attributable to shareholders of the listed company was -20.8826 million yuan, with a basic EPS of -0.04 yuan.

Gelonghui FinanceOct 29, 2024 06:37 ET

Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Simply Wall StOct 18, 2024 18:06 ET

Beihai Gofar Chuanshan Biological Chairman Resigns

MT NewswiresOct 18, 2024 06:14 ET

Director and President Pan Libin of Beihai Gofar Chuanshan Biological (600538.SH) has resigned.

beihai gofar chuanshan biological (600538.SH) announced that the board of directors received the company's...

Zhitong FinanceOct 16, 2024 05:45 ET